Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular approaches to antithrombotic therapy.

J Scharfstein1, J Loscalzo

  • 1Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston.

Hospital Practice (Office Ed.)
|May 15, 1992
PubMed
Summary

New antithrombotic agents offer improved specificity and safety for preventing and treating blood clots. These novel therapies aim to enhance pharmacologic interventions beyond current standards like warfarin and heparin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Clinical pharmacology and therapeutics·2019
Same author

Effect of antihypertensive therapy with angiotensin-converting enzyme inhibitors on chronic periodontitis: a case-control study.

Oral diseases·2016
Same author

A Dual Role for P2X7 Receptor during Porphyromonas gingivalis Infection.

Journal of dental research·2015
Same author

Developing new drug treatments in the era of network medicine.

Clinical pharmacology and therapeutics·2012
Same author

Detection of nitrosated proteins.

Current protocols in toxicology·2012
Same author

Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.

Amino acids·2011

Area of Science:

  • Pharmacology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Thrombosis poses a significant health risk, necessitating effective antithrombotic interventions.
  • Current treatments like warfarin and heparin have limitations in specificity and safety.
  • Advancements in understanding coagulation pathways have opened avenues for novel therapeutic strategies.

Purpose of the Study:

  • To review emerging direct and indirect thrombin inhibitors.
  • To evaluate their potential in prophylactic and acute antithrombotic therapy.
  • To compare their safety and efficacy profiles against established anticoagulants.

Main Methods:

  • Review of preliminary studies and clinical data on novel antithrombotic agents.
  • Comparative analysis of specificity and hemostatic safety.
  • Assessment of potential applications in various clinical settings.

Main Results:

  • New agents demonstrate direct or indirect inhibition of thrombin.
  • Preliminary data suggest greater specificity compared to warfarin and heparin.
  • These novel agents appear to offer improved hemostatic safety profiles.

Conclusions:

  • Emerging antithrombotic agents show promise for broader clinical application.
  • Enhanced specificity and safety could redefine anticoagulation therapy.
  • Further research is warranted to fully establish the clinical utility of these new agents.

Related Experiment Videos